Atlas Trials

MacroGenics

41 clinical trials · Sponsor

Sort:Newest firstOldest first

◉ Watch MacroGenics

RecordFirmDate
A Study of MGC028 in Participants With Advanced Solid Tumors (NCT06723236)MacroGenics2025-02-13
A Study of MGC026 in Participants With Advanced Solid Tumors (NCT06242470)MacroGenics2024-03-06
A Study of Lorigerlimab With Docetaxel or Docetaxel Alone in Participants With Metastatic Castration-Resistant Prostate Cancer (NCT05848011)MacroGenics2023-09-28
A Study of MGD020 Alone or Combined With MGD014 in Persons With HIV-1 on Antiretroviral Therapy (NCT05261191)MacroGenics2022-09-26
A Study of MGD024 in Patients With Relapsed or Refractory Hematologic Malignancies (NCT05362773)MacroGenics2022-07-13
A Study of MGC018 in Combination With MGD019 in Participants With Advanced Solid Tumors (NCT05293496)MacroGenics2022-04-19
Enoblituzumab Plus Retifanlimab or Tebotelimab in Head and Neck Cancer (NCT04634825)MacroGenics2021-03-17
Enoblituzumab Plus MGA012 or MGD013 in Squamous Cell Carcinoma of the Head and Neck (NCT04129320)MacroGenics2019-10-01
Combination Margetuximab, Retifanlimab, Tebotelimab, and Chemotherapy Phase 2/3 Trial in HER2+ Gastric/GEJ Cancer (NCT04082364)MacroGenics2019-09-30
MGD019 DART® Protein in Unresectable/Metastatic Cancer (NCT03761017)MacroGenics2018-12-12
MGC018 With or Without MGA012 in Advanced Solid Tumors (NCT03729596)MacroGenics2018-11-21
MGD009/MGA012 Combination in Relapsed/Refractory Cancer (NCT03406949)MacroGenics2018-02-27

Track MacroGenics automatically

Every clearance here is in the API, with alerts when new ones post.